Zydus Lifesciences Inches Up On Receiving Final Approval From USFDA For Norepinephrine Bitartrate InjectionUdaipur Kiran · 05:08 21 Jul 2022Zydus Lifesciences is currently trading at Rs. 359.30, up by 0.60 points or 0.17 % from its previous closing of Rs. 358.70 on the BSE. The scrip opened at Rs. 359.95 and has touched a high a… Read More